Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Balance Sheet 2020–2023
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 102.6M | 122.4M | 166.7M | 38.4M |
| Cash & Equivalents | 59.4M | 72.6M | 74.9M | 37.1M |
| Liabilities | ||||
| Total Liabilities | 12.0M | 12.5M | 10.7M | 2.8M |
| Long-Term Debt | — | — | — | — |
| Equity | ||||
| Shareholders' Equity | 90.6M | 109.9M | 156.0M | -22.5M |
Immuneering Corporation Balance Sheet — FAQ
Immuneering Corporation (IMRX) balance sheet over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's balance sheet history?
The chart and table above show Immuneering Corporation's balance sheet by year and by quarter, including the growth rate.